Using molecular epidemiology in assessing exposure for risk assessment

Annals of the New York Academy of Sciences

Volumn 895, Issue , 1999, Pages 101-111

  Schulte, Paul A ^a   Waters, M ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CANCER; CONFERENCE PAPER; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGY; HUMAN; MOLECULAR BIOLOGY; RISK ASSESSMENT;

EID: 0033404324     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb08079.x     Document Type: Conference Paper

References (38)

1. 1. Becking, G.C. 1995 Use of mechanistic information in risk assessment for toxic chemicals. Toxicol. Lett. 77: 15-24.
2. 2. McClellan, R.O. 1995. Risk assessment and biological mechanisms: lessons learned, future applications. Toxicology 102: 239-258.
3. 3. Nelson, D.I. 1997. Risk assessment in the workplace. In The Occupational Environment - Its Evaluation and Control, S. DiNardi, Ed.: 328-359. American Industrial Hygiene Association Press.
4. 4. US National Research Council (NRC). 1983.. Risk assessment in the Federal Government: Managing the Process. National Academy Press, Washington, D.C.
5. 5. Schulte, P.A. & F.P. Perera. 1993. Molecular epidemiology: Principles and practices. Academic Press, San Diego.
6. 6. Howe, G.R. 1998. Practical uses of biomarkers in population studies. In Biomarkers: Medical and Workplace Applications. M.L. Mendelsohn, L.C. Mohr & J.P. Peeters, Eds.: 41-49. John Henry Press, Washington, DC.
7. 7. White, E. 1997. Effects of biomarker measurement error on epidemiological studies. In Application of Biomarkers in Cancer Epidemiology. P. Toniolo et al., Eds.: 73-93. IARC Scientific Publication No. 142, Lyon.
8. 8. Hattis, D. & K. Silver. 1993. Use of biomarkers in Risk assessment. In Molecular Epidemiology: Principles and Practices. P.A. Schulte & F.P. Perera, Eds.: 257-273. Academic Press, San Diego.
9. 9. Saracci, R. 1997. Comparing measurements if biomarkers with other measurements of exposure. In Application of Biomarkers in Cancer Epidemiology. P. Toniolo et al., Eds.: 303-312. IARC Scientific Publication No 142, Lyon.
10. 10. Timbrell, J.A. 1998. Biomarkers in toxicology. Toxicology 129: 1-12.
11. 11. Qian, G.S., R.K. Ross, M.C. Yu, J.M. Yuan, Y.T. Gao, B.E. Henderson, G.N. Wogan & J.D. Groopman. 1994. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol. Biomarkers Prev. 3: 3-10.
12. 12. Steenland, K., J. Tucker, & A. Salvan. 1993. Problems in assessing the relative predictive value of internal markers versus external exposure in chronic disease epidemiology. Cancer Epidemiol. Biomarkers Prev. 2: 487-491.
13. 13. Joksic, G., & V. Spasojevic-Tisma. 1998. Chromosome analysis of lymphocytes from radiation workers in the tritium-applying industry. Int. Arch. Occup. Environ. Health 71: 213-220.
14. 14. Perera, F.P & L.A. Mooney. 1993. The role of molecular epidemiology in cancer prevention. In Cancer Prevention. V.T. DeVita, S. Hellman & S.A. Rosenberg, Eds.: 1-15. J.B. Lippincott, Philadelphia.
15. 15. Yang, Q. & M.J. Khoury. 1997. Evolving methods in genetic epidemiology: III. Gene-environment interaction in epidemiologic research. Epidemiologie Reviews 19: 33-43.
16. 16. Goldberg, M. & D. Hemon. 1993. Occupational epidemiology and assessment of exposure. Int. J. Epidemiol. 22(Suppl. 2): s5-s9.
17. 17. Stewart, P.A., A. Blair, M. Dosemici et al. 1991. Collection of exposure data for retrospective occupational epidemiologic studies. Appl. Occup. Environ. Hygiene 6: 280-289.
18. 18. Schulte, P.A., M. Boeniger, J.T. Walker, S. Schober, S.E. Perera, D.K. Gulati, J.P. Wojciechowski, A. Garza, R. Froelich, G. Strauss, W.E. Halperin, R. Herrick & J. Griffith. 1992. Biological markers in hospital workers exposed to low levels of ethylene oxide. Mutat. Res. 278: 237-151.
19. 19. Munoz, A. & S.J. Gange. 1998. Methodological issues for biomarkers and intermediate outcomes in cohort studies. Epidemiologic Rev. 20: 29-42.
20. 20. Rothman, N., W.F. Stewart & P.A. Schulte. 1995 Incorporating biomarkers into cancer epidemiology: a matrix of biomarker and study design categories. Cancer Epidemiol, Biomarkers Prev. 4: 301-311.
21. 21. Hagmar, L., L. Brogger, I.L. Hansteen, S. Heim, B. Hogstedt, L. Knudsen, B. Lambert, K. Linnainmaa, F. Mitelman, I. Nordenson, C. Reuterwall, S. Salomaa, S. Skerfving & M. Sorsa. 1994. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic Study Group on the Health Risk of Chromosome Damage. Cancer Res. 54: 2919-2922.
22. 22. Nigro, J.M. & S.J. Baker. 1989. Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708.
23. 23. Hernandez-Boussard, T.M. & P. Hainart. 1998. A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p 53 database. Env. Health Perspect. 106: 385-391.
24. 24. Greenblatt, M., W. Bennett, M. Hollstein & C. Harris. 1994. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathegenesis. Cancer Res. 54: 4855-4878.
25. 25. Vineis, P. & P.A. Schulte. 1995. Scientific and ethical aspects of genetic screening of workers: the case of the N-acetyltranferase phenotype. J. Clin. Epidemiol. 48: 189-197.
26. 26. Rothman, N., W.F. Stewart, N.E. Caporaso & R.B. Hayes. 1993. Misclassification of genetic susceptibility biomarkers: implication for case-control studies and cross population comparisons. Cancer Epidemiol. Biomarkers Prev. 2: 299-303.
27. 27. Cartwright, R.A., R.W. Glashan, H.J. Rogers et al. 1982. Role of N-acetyltransferase phenotype in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 11: 842-846.
28. 28. Taylor, J.A., D.M. Umbach, E. Stephens et al. 1998. The role of N-acetylation polymorphisms in smoking - associated bladder cancer: evidence of a gene - gene-exposure three-way interaction. Cancer Res. 58: 3403-3610.
29. 29. Bois, F.Y., G. Krowech & L. Zeise. 1995. Modeling human interindividual variability in metabolism and risk: The example of 4-aminobiphenyl. Risk Analysis 15: 205-213.
30. 30. Calabrese, E.J. 1997 Role of genetic factors in environmentally induced toxic response: historical consideration, present status and future directions. University of Massachusetts, Amherst.
31. 31. Renwick, A.G. & N.R. Lazarus. 1998. Human variability and noncancer risk assessment - an analysis of the default uncertainty factor. Reg. Tox. Pharmacol. 27: 3-20.
32. 32. Rappaport, S.M. 1985. Smoothing of exposure variability at the receptor: implications for health standards. Ann. Occup. Hyg. 29: 201-214.
33. 33. Rappaport, S.M., E. Symanski, J.W. Yager & L.L. Kupper. 1995. The relationship between environmental monitoring and biologic markers in exposure assessment. Env Health Perspectives 103(Suppl. 3): 49-53.
34. 34. Brunekreef, B., D. Noy & P. Clausing. 1987. Variability of exposure measurements in environmental epidemiology. Am. J. Epidemiology 125: 892-898.
35. 35. Tucker, J.D., E.J. Tawn, D. Holdsworth, S. Morris et al. 1997 Biological dosimetry of radiation workers at the Sellafield nuclear facility. Radiation Res. 148: 216-26.
36. 36. Ramsey, M.J., D.H. Moore, J.F. Briner et al. 1995. The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosomal painting. Mutation Research 338: 95-106.
37. 37. Woychik, R.R., M.L. Klebig, M.J, Justice, T.R. Magnuson & E.D. Avner. 1998. Functional genomics in the post-genome era. Mut. Res. 400: 3-14.
38. 38. Schulte, P.A., D. Hunter, N. Rothman. 1997. Ethical and social issues in the use of biomarkers in epidemiological research. In Application of Biomarkers in Cancer Epidemiology. P. Toniolo, P. Boffetta, D.E.G. Shuker et al., Eds.: 313-318. IARC Scientific Publications No. 142, Lyon.